
GLP-1 medications have changed the way we approach weight loss, but they may not be enough for some patients. Still, they have a place in improving health outcomes both before and after bariatric surgery.
What GLP-1 RAs Can Do
GLP-1 receptor agonists (GLP-1 RAs) are changing the way many clinicians approach medical weight management. These medications work by mimicking a naturally occurring hormone that helps regulate blood sugar, slow stomach emptying, and signal fullness to the brain.
For patients with excess weight to lose, GLP-1 RAs can produce meaningful weight loss when paired with lifestyle changes such as improved nutrition and increased physical activity. In some cases, these medications help people establish healthier eating patterns and build confidence in their ability to manage weight.
GLP-1 therapies can also reduce the risk of complications linked to metabolic disease, and many individuals also see improvements in related health conditions, including high blood sugar, high blood pressure, and abnormal cholesterol levels. Patients with type 2 diabetes often benefit from improved glucose control, and some medications in this class have demonstrated cardiovascular benefits in high-risk populations.
What GLP-1 RAs Can’t Do
Despite their effectiveness, GLP-1 medications are not a cure for obesity, and their benefits typically continue only while the medication is being used. When therapy stops, appetite signals and metabolic processes gradually return to their previous state, and weight regain is likely to occur.
There are also limits in the amount of weight loss GLP-1 drugs typically produce. Results vary widely from person to person, and some individuals may not achieve the level of weight reduction needed to improve certain obesity-related conditions. Genetics, metabolic adaptation, existing health conditions, weight at the start of therapy, and long-term weight history influence how the body responds. It is also well known that many patients regain the weight after stopping GLP-1 medications.
For individuals with severe obesity or longstanding metabolic disease, medical therapy alone may not be sufficient to produce durable weight loss or fully address related health risks. In these situations, other treatment strategies may be considered.
When It’s Time for a New Approach
Body mass index (BMI) and overall health status help determine which treatment approach may be most effective. Individuals with higher BMIs – particularly those with obesity-related conditions such as type 2 diabetes, sleep apnea, or hypertension – may require more substantial and sustained weight loss to improve their health.
GLP-1 therapy helps initiate progress. Patients who use or have used GLP-1 medications consistently but are unable to reach or maintain sufficient weight reduction may benefit from exploring surgical treatments. Bariatric surgery is not a replacement for medical therapy, but rather another tool in the continuum of obesity care. It has great potential as part of a personalized strategy to achieve long-term metabolic health.
Note: GLP-1 medications need to be discontinued 10-14 days prior to bariatric surgery. Because of the effect of slowed gastric emptying, continuing these medications into surgery can raise your risk of complications. If you are taking GLP-1 drugs, let your doctor know so you can both plan your surgery accordingly.
Benefits of GLP-1 Therapy Before and After Surgery
We are increasingly seeing the benefits of GLP-1 RA use prior to bariatric surgery. Though it seems counterintuitive, some weight loss before the procedure is beneficial. Weight loss achieved through GLP-1 therapy can help lower surgical risk by improving blood sugar control, reducing liver size, and decreasing inflammation. Even modest weight reduction before surgery can make the procedure technically easier and support a smoother recovery.
GLP-1 therapy prior to weight loss surgery can also help patients build habits that support long-term success. Learning to recognize fullness cues, reduce portion sizes, and make healthier food choices prepares individuals for the lifestyle adjustments that accompany bariatric surgery.
We’re also recognizing the benefits of GLP-1 medications after surgery. Patients typically experience the most substantial weight loss in the first 12 to 18 months after surgery, along with improvements in obesity-related conditions. After this initial rapid weight loss, the body can go through metabolic adaptation. This is when the body adjusts to the lower weight by slowing metabolism and increasing hunger signals to conserve energy, and patients may notice a plateau or even weight regain.
GLP-1 RAs can help patients get back on track when this occurs. They can be used to help support additional weight loss, prevent weight regain, or address persistent metabolic conditions. When used thoughtfully, medication and surgery together can form a powerful, complementary approach to long-term weight management.
If you’ve been using GLP-1 medications but feel your progress has stalled, it may be time to explore the full range of treatment options. The bariatric specialists at MASJax will evaluate your health history, treatment goals, and current therapy to determine whether surgical care is the appropriate next step in your weight management journey. With the right combination of medical support and personalized care, lasting health improvements are possible. Reach out to the team to schedule your consultation.
MASJax is the longest-established bariatric program in the Jacksonville area, with a level of experience that sets the standard for care in the region. Our program holds a Center of Excellence designation through the American Society for Metabolic and Bariatric Surgery MBSAQIP program and is also recognized as a Blue Distinction Center for Bariatric Surgery, reflecting our commitment to the highest quality standards.
MASJax surgeons routinely perform advanced bariatric procedures, including sleeve gastrectomy, gastric bypass, duodenal switch, and complex revisional bariatric surgery. As specialists in minimally invasive techniques, we offer laparoscopic and robotically assisted procedures using the da Vinci Surgical System for appropriate patients.